Pharma 2010: Silicon reality

This white paper by IBM Business Consulting Services identifies the seven key technologies that IBM believes will drive innovation in the life sciences over the next decade. These seven technologies are Petaflop and grid computing, Predictive biosimulation, Pervasive computing, Smart tags, Advanced storage solutions, Web-scale mining and advanced text analytics, and Process analytical technology. All seven technologies once belonged in the realm of science fiction, but they are fast becoming fact – the “silicon reality” to which the title of white paper refers. This paper describes how the molecular sciences will help the industry define diseases more accurately and create healthcare packages for patients with specific disease subtypes, rather than making one-size-fits-all drugs for patients with similar symptoms but essentially different diseases.

The various section of this white paper discusses the seven technologies that IBM Business Consulting Services thinks will be vital during the coming decade. The section after that elaborates on how these technologies will help the industry. The final section examines the changing role of IT. According to this white paper the technological advances of the past few years have huge implications for Pharma. The “silicon rally” that lay on the horizon at the start of the decade has turned into “silicon reality.” It has produced, or is about to produce, the key tools for discovering, developing, manufacturing and selling targeted treatment solutions – the primary source for creating future shareholder value.

• Email This Page
• Print This Page